⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24585208 | 0.79 | CA12 (0.42) | — | |
| SCHEMBL503681 | 0.74 | — | — | |
| SCHEMBL27793697 | 0.74 | — | — | |
| SCHEMBL25962796 | 0.72 | CARM1 (0.31) | — | |
| SCHEMBL6254221 | 0.70 | ALDH1A1 (0.38) | — | |
| SCHEMBL19292654 | 0.70 | — | — | |
| SCHEMBL10403868 | 0.69 | — | — | |
| SCHEMBL27770004 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL27593113 | 0.69 | EGFR (0.31) | — | |
| SCHEMBL19561622 | 0.69 | EGFR (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4719593-A1 | ENANTIOSELECTIVE PREPARATION METHOD | Immunahr AB (SE) | 2026-04-08 | — | — | EP | disclosed |
| EP-4577549-A1 | COMPOUNDS AND METHODS FOR MODULATING HER2 | Iambic Therapeutics, Inc. (US) | 2025-07-02 | — | — | EP | disclosed |
| WO-2024245895-A1 | ENANTIOSELECTIVE PREPARATION METHOD | ANAMAR AB (SE) | 2024-12-05 | — | — | WO | disclosed |
| WO-2024044570-A1 | COMPOUNDS AND METHODS FOR MODULATING HER2 | IAMBIC THERAPEUTICS, INC. (US) | 2024-02-29 | — | — | WO | disclosed |
| WO-2008150118-A2 | NOVEL AMIDE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS | HANMI PHARM. CO., LTD. (KR) | 2008-12-11 | — | — | WO | disclosed |